Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients

BACKGROUND: Chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are controversial in the treatment of patients with brain metastases from non-small-cell lung cancer (NSCLC). METHODS: We retrospectively studied the effects of solely localized treatment or localized tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yun, Huang, Zhiyu, Fang, Luo, Miu, Lulu, Lin, Nengming, Gong, Lei, Yu, Haifeng, Yang, Haiyan, Mao, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862699/
https://www.ncbi.nlm.nih.gov/pubmed/24353431
http://dx.doi.org/10.2147/OTT.S52172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862699/
https://www.ncbi.nlm.nih.gov/pubmed/24353431
http://dx.doi.org/10.2147/OTT.S52172

Ejemplares similares